[Effect of typhus endotoxin on interoceptive reflex activity].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 5843035)

Published in Fiziol Norm Patol on January 29, 1966

Authors

G G Popovici, I Pencea, V Manoilă, N Lascu, R Hafner, L Moisă, M Negoiţă, E Botez

Articles by these authors

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (1997) 2.84

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med (1995) 2.63

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med (1993) 2.55

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14

Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis (1997) 2.07

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. JAMA (2000) 1.98

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1993) 1.82

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am J Med (1997) 1.67

Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. N Engl J Med (1998) 1.30

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother (2001) 1.24

Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team. AIDS (1997) 1.22

A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clin Infect Dis (1999) 1.20

Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.20

From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. J Infect Dis (1991) 1.13

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Ann Intern Med (2000) 1.11

Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group. J Infect Dis (1996) 1.08

Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis (2001) 1.06

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG). Clin Infect Dis (1998) 1.05

Comparison of ketorolac and diclofenac in the treatment of renal colic. Eur J Clin Pharmacol (1998) 1.01

Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. J Infect Dis (2000) 1.00

Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group. AIDS (1996) 0.96

Toxoplasmic encephalitis. AIDS (1990) 0.96

Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii. Antimicrob Agents Chemother (1996) 0.96

In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053). J Infect Dis (1991) 0.95

Genetic variation in the primary structure of the beta chain of rabbit hemoglobin. Ann N Y Acad Sci (1974) 0.94

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group. Control Clin Trials (1998) 0.93

Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. J Infect Dis (1994) 0.86

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. J Antimicrob Chemother (2009) 0.84

Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (2000) 0.84

The influence of certain antibiotics on intestinal motor activity. Arch Int Pharmacodyn Ther (1965) 0.81

A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis (1999) 0.79

Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS. Lancet (1992) 0.79

[Primary prevention of cerebral toxoplasmosis in patients with HIV infection: results of a double-blind randomized trial, pyrimethamine versus placebo]. Rev Med Interne (1993) 0.77

[Effect of dapsone on survival in HIV infected patients: a meta- analysis of finished trials]. Rev Epidemiol Sante Publique (2000) 0.77

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l. AIDS (2001) 0.77

Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.77

Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group. Clin Infect Dis (1997) 0.77

Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. AIDS (2001) 0.77

A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team. AIDS (1998) 0.76

Modulation of the immune response by aerodin. II. Influence on the antiinfectious resistance in rabbits and guinea pigs experimentally infected by Francisella tularensis and Pseudomonas aeruginosa. Arch Roum Pathol Exp Microbiol (1982) 0.76

Acute fulminant toxoplasma meningoencephalitis in a homosexual man. Acta Neuropathol (1983) 0.76

[The role of the library and publications of the Société des Médecins et des Naturalistes in the spread of sciences and in professional education of physicians]. Rev Med Chir Soc Med Nat Iasi (1971) 0.75

[Pharmacodynamic research on some new synthetic substances of the diacylmethylenediamine class. I. Electroencephalographic changes]. Rev Med Chir Soc Med Nat Iasi (1968) 0.75

[Some current problems concerning the pharmacodynamics of drugs. Inaugural lecture given 17 September 1973 at the opening of the university year 1973-1974 at the Institut de medicina şi farmacie, Jassy]. Rev Med Chir Soc Med Nat Iasi (1974) 0.75

[On 210 cases of cranial and cerebral injuries associated with other injuries]. Rev Med Chir Soc Med Nat Iasi (1971) 0.75

Comparative experimental study on the changes in the blood acid-base balance after 60cobalt gamma-irradiation in dogs and pigs. Rev Roum Physiol (1974) 0.75

[Changes of the acetylcholine-cholinesterase system of the brain after administration of some anticonvulsant substances]. Rev Med Chir Soc Med Nat Iasi (1969) 0.75

[Apropos of the adaptation of interoceptive reflexes to the action of some antibiotics]. Antibiotiki (1967) 0.75

[Cholecystokinetic action of an alkaloid extract of Chelidonium majus]. Rev Med Chir Soc Med Nat Iasi (1981) 0.75

[Male subfertility and oral bacterial diseases]. Zentralbl Gynakol (1990) 0.75

[Considerations on 20 cases of hepato-splenomegalic cirrhosis in children]. Rev Med Chir Soc Med Nat Iasi (1974) 0.75

[Local anti-inflammatory and anti-actinic action of oil extracted from Plantago sp. seeds]. Rev Med Chir Soc Med Nat Iasi (1976) 0.75

[Effects of mucilage extracted from the seeds of Plantago sp. on the digestive tract]. Rev Med Chir Soc Med Nat Iasi (1977) 0.75

[Malignant lymphogranulomatosis of gastric localization]. Chirurgia (Bucur) (1973) 0.75

[Incidence of septicemia in a department of general surgery]. Rev Med Chir Soc Med Nat Iasi (1973) 0.75

Potentiation of the antiinflammatory action of prednison by several synthetic antihistaminics. Rev Med Chir Soc Med Nat Iasi (1974) 0.75

[On the ganglioplegic effect of some anticonvulsant substances of the diacylmethylene-diamine group]. Rev Med Chir Soc Med Nat Iasi (1968) 0.75

[Effect of chloramphenicol on respiration and glycolysis of rat brain homogenates]. Fiziol Norm Patol (1971) 0.75

[Scientific research in the field of physiological sciences]. Rev Med Chir Soc Med Nat Iasi (1971) 0.75

[Effect of neomycin and streptomycin on respiration and glycolysis at the level of the diaphragm in rats]. Fiziol Norm Patol (1969) 0.75

[On a case of acquired hemolytic jaundice associated with hepatic cirrhosis]. Rev Med Chir Soc Med Nat Iasi (1973) 0.75

[Anatomo-clinical aspects of 2 cases of aberrant pancreas]. Rev Med Chir Soc Med Nat Iasi (1974) 0.75

Clinical programs for clinical research on AIDS: description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection. Eur J Clin Microbiol Infect Dis (1991) 0.75

The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet. Antiviral Res (1998) 0.75

[On 115 cases of rectal cancer]. Chirurgia (Bucur) (1973) 0.75

[Correlations between the secondary effects of some antibiotics and metabolic changes in animal cells]. Rev Med Chir Soc Med Nat Iasi (1971) 0.75

[On the hypotensive action of some hydrazino-pyridazine derivatives. I]. Rev Med Chir Soc Med Nat Iasi (1968) 0.75

[Comparative effects of pure chloramphenicol and chloramphenicol succinate on respiration and glycolysis of rat liver homogenate]. Fiziol Norm Patol (1970) 0.75

[Influence of chloramphenicol on the reactivity and adaptation of interoceptive reflexes following perfusion of intestinal interoceptors with typhus endotoxin]. Fiziol Norm Patol (1966) 0.75

[Removal of tattoos with the Nd:YAG laser]. Hautarzt (1987) 0.75

The influence of some antibiotics on hexokinase and pyruvate-kinase activity in the rat liver and kidney. Arch Int Pharmacodyn Ther (1971) 0.75

[Possible influence of birth weight and duration of pregnancy on scholastic performance of children at the beginning of school]. Pediatria (Bucur) (1973) 0.75

[Risk factors of cerebral toxoplasmosis in patients with HIV infection: data of a primary prevention trial]. Rev Med Interne (1993) 0.75

The mechanism of action of streptomycin on hepatic glucose-6-P-NADP-oxido-reductase (G6PDH) activity. Arch Int Pharmacodyn Ther (1969) 0.75

[Study of basal metabolism and oxygen consumption of brain tissue after administration of anticonvulsant substances]. Rev Med Chir Soc Med Nat Iasi (1971) 0.75

[Posttraumatic diaphragmatic hernia]. Chirurgia (Bucur) (1973) 0.75

[Epidemiological research carried out in an old source of tularemia]. Arch Roum Pathol Exp Microbiol (1964) 0.75

[Study of some pharmacodynamic actions of a product of plant origin, "Diurocist"]. Rev Med Chir Soc Med Nat Iasi (1975) 0.75

[Studies of the rectal resorption of strychnine sulfate from suppositories prepared with indigenous excipients]. Rev Med Chir Soc Med Nat Iasi (1977) 0.75

[Perforated intestinal ulcer]. Chirurgia (Bucur) (1971) 0.75

The action of some antibiotics on tissular diffusibility. Rev Roum Physiol (1971) 0.75

Influence of some antibiotics on stationary NAD and NADP concentrations in rat liver and kidney. Arch Int Pharmacodyn Ther (1970) 0.75

The influence of some antibiotics on uterine motor activity in the guinea pig. Arch Int Pharmacodyn Ther (1967) 0.75

A new semisynthetic penicillin--SGD2. Determination of its acute toxicity and control of the hypotensive effect. Rev Med Chir Soc Med Nat Iasi (1971) 0.75